Current role
John R. Pinion II
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John R. Pinion II
The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $4,129,753 for John R. Pinion II in fiscal 2024, including a base salary of $570,366. Disclosed compensation is on record for 8 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ultragenyx Pharmaceutical Inc. (RARE)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $570,366 | $4,129,753 |
| 2023 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $552,092 | $4,049,853 |
| 2022 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $533,315 | $3,706,511 |
| 2021 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $509,939 | $3,263,220 |
| 2020 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $480,063 | $2,177,640 |
| 2019 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $447,690 | $3,370,530 |
| 2018 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $430,320 | $1,601,074 |
| 2017 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Quality Officer and Executive Vice President, Translational Sciences | $412,568 | $1,919,329 |
Recent activity
No call appearances or filed executive changes recorded yet.